Related content

Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimer’s Disease with Cerebrovascular Disease

By Small G.  

CNS Drugs, Vol. 17, Iss. 12, 2003-01 ,pp. : 905-914

Adis International

Access to resources Recommend Favorite

Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer’s Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 6, 2016-02 ,pp. : 688-700

Bentham Science Publishers

Access to resources Recommend Favorite

Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease

By Van Dam Debby   Coen Katrien   De Deyn Peter  

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 37-43

Springer Publishing Company

Access to resources Recommend Favorite

The Effects of Aerobic Exercise on Cognitive Function of Alzheimer’s Disease Patients

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 10, 2015-12 ,pp. : 1292-1297

Bentham Science Publishers

Access to resources Recommend Favorite

Aging process, cognitive decline and Alzheimer`s disease: can strength training modulate these responses?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 9, 2015-11 ,pp. : 1209-1213

Bentham Science Publishers

Access to resources Recommend Favorite